Expert Financial Analysis and Reporting

Recent Reports

• Antares Pharma: FDA Action to not Approve Xyosted on its October 20, 2017 PDUFA Date is Perplexing (ATRS, Buy, $2.23) (0)

Recent Blogs

• Update on Currently Recommended Stocks of SmithOnStocks.com (0)
• Repligen: More Detailed Analysis on GE Decision to Manufacture Protein A (0)
• Novartis Releases Three Month Interim Data for JULIET Trial of CTL-019 in r/r DLBCL (0)
• Portola: Reiterating Buy and Refuting Recent Negative Blog by Adam F-stein (PTLA, Buy, $54.12) (0)
• FDA Announces July 12 AdCom Meeting for CTL-019: Thoughts on How This Might Affect Investor Perceptions of Kite (KITE, Neutral, $80.25) and Cryoport (CYRX, Buy, $3.89) (0)
• Northwest Biotherapeutics: Thoughts on Why the Phase 3 Trial of DCVax-L is Ongoing (NWBO, BUY, $0.17) (0)
• Northwest Biotheraputics to Make Presentation at ASCO Today Monday June 5, 2017 (0)
• Northwest Biotherapeutics, Bristol-Myers Squibb: Success for the Yervoy-Opdivo Combination in CHECKMATE-214 Trial Obviously is a Major Positive for BMY, but also has Important Implications for NWBO (NWBO, Buy, $0.19) (BMY, $60.80, Buy) (0)
• Key Investment Considerations Relating to Much Anticipated CAR-T Product Launches By Kite and Novartis Later This Year (0)
• Portola: September 4 Conference Call Provides Update on Potential Launch Date for Bevyxxa and Announces Price (PTLA, Buy, $57.29) (0)
• Cytokinetics: Comments on the Upside Move Today (CYTK, Buy, $12.90) (0)

Social Feeds

• • $atrs FDA Action to not Approve Xyosted on its October 20, 2017 PDUFA Date is Perplexing (ATRS, Buy, $2.23) https://t.co/t3wMN6JEhC, Oct 19
  • $RGEN, $CYRX,, $ALIM, $AGEN SmithOnStocks recommendations w/o strong near term catalyst https://t.co/6IlFpbW2Lb, Oct 03
  • $CYTK, $ATRS, $NWB0, $PTLA Smith on stocks recommendations with near term catalysts https://t.co/6IlFpbW2Lb, Oct 03
  • $RGEN More Detailed Analysis on GE Decision to Manufacture Protein A https://t.co/gpmTLnVVxG, Sep 28
  • $RGEN Initial Thoughts on the GE Decision to Launch a New Protein A Product https://t.co/FTN3CkhSSh, Sep 27